Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eloxatin 100mg/20ml concentrate for inf vials
0801050ALBBABAB
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 200mg/40ml concentrate for inf vials
0801050ALBBACAE
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 50mg/10ml concentrate for inf vials
0801050ALBBAAAA
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.